Early assessment of breast cancer response to neoadjuvant chemotherapy by semi-quantitative analysis of high-temporal resolution DCE-MRI: Preliminary results

Magnetic Resonance Imaging

Volumn 31, Issue 9, 2013, Pages 1457-1464

  Abramson, Richard G ^a   Li, Xia ^a   Hoyt, Tamarya Lea ^a   Su, Pei Fang ^b   Arlinghaus, Lori R ^a   Wilson, Kevin J ^a   Abramson, Vandana G ^a   Chakravarthy, A Bapsi ^a   Yankeelov, Thomas E ^a,c,d  

^a VANDERBILT UNIVERSITY   (United States)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

DCE MRI; Enhancement kinetics; Imaging biomarkers; Neoadjuvant chemotherapy; Neoadjuvant therapy; Operable breast cancer; Preoperative chemotherapy; Primary chemotherapy; Response assessment

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EVEROLIMUS; PACLITAXEL; PLACEBO; TRASTUZUMAB; CONTRAST MEDIUM;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER SIZE; CANCER SURGERY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MASTECTOMY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL RESOLUTION; OUTCOME ASSESSMENT; PARTIAL MASTECTOMY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TREATMENT DURATION; VOXEL BASED MORPHOMETRY; ADJUVANT CHEMOTHERAPY; AREA UNDER THE CURVE; BREAST NEOPLASMS; CHEMISTRY; CLINICAL TRIAL; COMPUTER GRAPHICS; FEMALE; MIDDLE AGED; OBSERVER VARIATION; PATHOLOGY; PROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

ADULT; AREA UNDER CURVE; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMPUTER GRAPHICS; CONTRAST MEDIA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOADJUVANT THERAPY; OBSERVER VARIATION; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84885077368     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2013.07.002     Document Type: Article

References (39)

1. Kaufmann M., von Minckwitz G., Bear H.D., et al. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006. Ann Oncol 2007, 18:1927-1934.
2. Mauri D., Pavlidis N., Ioannidis J.P. Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis. J Natl Cancer Inst 2005, 97:188-194.
3. Fisher B., Bryant J., Wolmark N., et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 1998, 16:2672-2685.
4. Chollet P., Amat S., Cure H., et al. Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer. Br J Cancer 2002, 86:1041-1046.
5. Wolff A.C., Berry D., Carey L.A., et al. Research issues affecting preoperative systemic therapy for operable breast cancer. J Clin Oncol 2008, 26:806-813.
6. Li S.P., Makris A., Beresford M.J., et al. Use of dynamic contrast-enhanced MR imaging to predict survival in patients with primary breast cancer undergoing neoadjuvant chemotherapy. Radiology 2011, 260:68-78.
7. Londero V., Bazzocchi M., Del Frate C., et al. Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy. Eur Radiol 2004, 14:1371-1379.
8. Yeh E., Slanetz P., Kopans D.B., et al. Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol 2005, 184:868-877.
9. Yankeelov T.E., Gore J.C. Dynamic contrast enhanced magnetic resonance imaging in oncology: theory, data acquisition, analysis, and examples. Curr Med Imaging Rev 2009, 3:91-107.
10. Ah-See M.L., Makris A., Taylor N.J., et al. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer. Clin Cancer Res 2008, 14:6580-6589.
11. Manton D.J., Chaturvedi A., Hubbard A., et al. Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy. Br J Cancer 2006, 94:427-435.
12. Padhani A.R., Hayes C., Assersohn L., et al. Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results. Radiology 2006, 239:361-374.
13. Pickles M.D., Lowry M., Manton D.J., Gibbs P., Turnbull L.W. Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy. Breast Cancer Res Treat 2005, 91:1-10.
14. Wasser K., Klein S.K., Fink C., et al. Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution. Eur Radiol 2003, 13:80-87.
15. El Khoury C., Servois V., Thibault F., et al. MR quantification of the washout changes in breast tumors under preoperative chemotherapy: feasibility and preliminary results. AJR Am J Roentgenol 2005, 184:1499-1504.
16. Hylton N. Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J Clin Oncol 2006, 24:3293-3298.
17. Loo C.E., Teertstra H.J., Rodenhuis S., et al. Dynamic contrast-enhanced MRI for prediction of breast cancer response to neoadjuvant chemotherapy: initial results. AJR Am J Roentgenol 2008, 191:1331-1338.
18. Martincich L., Montemurro F., De Rosa G., et al. Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer Res Treat 2004, 83:67-76.
19. El Khouli R.H., Macura K.J., Barker P.B., Habba M.R., Jacobs M.A., Bluemke D.A. Relationship of temporal resolution to diagnostic performance for dynamic contrast enhanced MRI of the breast. J Magn Reson Imaging: JMRI 2009, 30:999-1004.
20. Hylton N.M., Blume J.D., Bernreuter W.K., et al. Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy-results from ACRIN 6657/I-SPY Trial. Radiology 2012, 263:663-672.
21. El Khouli R.H., Macura K.J., Jacobs M.A., et al. Dynamic contrast-enhanced MRI of the breast: quantitative method for kinetic curve type assessment. AJR Am J Roentgenol 2009, 193:W295-W300.
22. Macura K.J., Ouwerkerk R., Jacobs M.A., Bluemke D.A. Patterns of enhancement on breast MR images: interpretation and imaging pitfalls. Radiographics 2006, 26:1719-1734.
23. Baek H.M., Chen J.H., Nie K., et al. Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy. Radiology 2009, 251:653-662.
24. Chen X., Moore M.O., Lehman C.D., et al. Combined use of MRI and PET to monitor response and assess residual disease for locally advanced breast cancer treated with neoadjuvant chemotherapy. Acad Radiol 2004, 11:1115-1124.
25. Gounaris I., Provenzano E., Vallier A.L., et al. Accuracy of unidimensional and volumetric ultrasound measurements in predicting good pathological response to neoadjuvant chemotherapy in breast cancer patients. Breast Cancer Res Treat 2011, 127:459-469.
26. Jacobs M.A., Ouwerkerk R., Wolff A.C., et al. Monitoring of neoadjuvant chemotherapy using multiparametric, (2)(3)Na sodium MR, and multimodality (PET/CT/MRI) imaging in locally advanced breast cancer. Breast Cancer Res Treat 2011, 128:119-126.
27. Jacobs M.A., Stearns V., Wolff A.C., et al. Multiparametric magnetic resonance imaging, spectroscopy and multinuclear ((2)(3)Na) imaging monitoring of preoperative chemotherapy for locally advanced breast cancer. Acad Radiol 2010, 17:1477-1485.
28. Keam B., Im S.A., Koh Y., et al. Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy. BMC Cancer 2011, 11:452.
29. Kolesnikov-Gauthier H., Vanlemmens L., Baranzelli M.C., et al. Predictive value of neoadjuvant chemotherapy failure in breast cancer using FDG-PET after the first course. Breast Cancer Res Treat 2012, 131:517-525.
30. Meisamy S., Bolan P.J., Baker E.H., et al. Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy-a pilot study at 4T. Radiology 2004, 233:424-431.
31. Park S.H., Moon W.K., Cho N., et al. Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. Radiology 2010, 257:56-63.
32. Partridge S.C., Gibbs J.E., Lu Y., Esserman L.J., Sudilovsky D., Hylton N.M. Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol 2002, 179:1193-1199.
33. Partridge S.C., Gibbs J.E., Lu Y., et al. MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. AJR Am J Roentgenol 2005, 184:1774-1781.
34. Sharma U., Danishad K.K., Seenu V., Jagannathan N.R. Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. NMR Biomed 2009, 22:104-113.
35. Tateishi U., Miyake M., Nagaoka T., et al. Neoadjuvant chemotherapy in breast cancer: prediction of pathologic response with PET/CT and dynamic contrast-enhanced MR imaging-prospective assessment. Radiology 2012, 263:53-63.
36. Abramson R.G., Arlinghaus L.R., Weis J.A., et al. Current and emerging quantitative magnetic resonance imaging methods for assessing and predicting the response of breast cancer to neoadjuvant therapy. Breast cancer: targets and therapy 2012, 2012:139-154.
37. Yu H.J., Chen J.H., Mehta R.S., Nalcioglu O., Su M.Y. MRI measurements of tumor size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy. J Magn Reson Imaging 2007, 26:615-623.
38. Yu Y., Jiang Q., Miao Y., et al. Quantitative analysis of clinical dynamic contrast-enhanced MR imaging for evaluating treatment response in human breast cancer. Radiology 2010, 257:47-55.
39. Li K.L., Partridge S.C., Joe B.N., et al. Invasive breast cancer: predicting disease recurrence by using high-spatial-resolution signal enhancement ratio imaging. Radiology 2008, 248:79-87.